Related Experiment Video
Updated: Jun 17, 2025

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
Adipose tissue in older individuals: a contributing factor to sarcopenia
Tiantian Wang1, Dong Zhou1, Zhen Hong1
1Department of Neurology, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, Sichuan, China; Institute of Brain Science and Brain-inspired Technology of West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Neurology, Chengdu Shangjin Nanfu Hospital, Chengdu, Sichuan, China.
Sarcopenia, a muscle decline in aging, is linked to fat tissue changes, gut microbes, and inflammation. New therapies targeting these factors may improve health in older adults.
Area of Science:
- Gerontology
- Metabolism
- Immunology
Background:
- Sarcopenia, a geriatric syndrome of muscle functional decline, significantly impacts elderly health.
- Age-related inflammation and metabolic dysfunction are increasingly recognized as key drivers of sarcopenia.
- Interactions between adipose tissue, skeletal muscle, and gut microbiota are implicated in sarcopenia development.
Purpose of the Study:
- To explore the relationship between adipose tissue, skeletal muscle, and sarcopenia.
- To investigate the roles of cellular senescence, gut dysbiosis, and inflammation in age-related muscle loss.
- To identify novel therapeutic targets for sarcopenia.
Main Methods:
- Review of current literature on sarcopenia, adipose tissue, and inflammation.
- Analysis of the impact of aging, obesity, and gut microbiota on sarcopenia.
- Exploration of molecular mechanisms involving adipokines, senescent cells, and microbial imbalances.
Main Results:
- Cellular senescence in adipose and muscle tissue, along with gut dysbiosis, contributes to inflammation and sarcopenia.
- Adipose tissue acts as an endocrine organ, influencing muscle health through secreted molecules (adipokines).
- Age-related sarcopenia and adipose tissue dysfunction are characterized by chronic inflammation and metabolic dysregulation.
Conclusions:
- Novel therapeutic strategies for sarcopenia may involve targeting G protein-coupled receptor (GPCR) agonists, transient receptor potential (TRP) channels, and senolytics.
- Combined approaches using antidiabetic drugs with probiotics and prebiotics show promise.
- Mitigating inflammation and metabolic dysfunction through targeted therapies is crucial for combating sarcopenia.
More Related Videos
12:59Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
10:37Author Spotlight: Decellularization-Based Quantification of Skeletal Muscle Fatty Infiltration
Published on: June 9, 2023
Related Concept Videos
The Effect of Aging on Tissues
Hypodermis
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Obesity
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Changes in the Appendicular Skeleton with Age
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...